Approximately 10% of AML cases are caused by the t(8;21) translocation resulting in the RUNX1::ETO gene product that inhibits granulocytic differentiation and promotes excessive proliferation [39]. This evidence concerns the gene RUNX1 and acute myeloid leukemia.